BLASUBCUTANEOUSINJECTABLE
Approved
Dec 2024
Lifecycle
Growth
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 7h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
STEQEYMA (ustekinumab-stba) is a monoclonal antibody biosimilar to the reference ustekinumab, approved by the FDA on December 17, 2024. Ustekinumab is an IL-12/IL-23 inhibitor used to treat autoimmune and inflammatory conditions. This subcutaneous injectable targets patients with conditions such as psoriasis, psoriatic arthritis, and Crohn's disease.
Growth
Early-stage biosimilar in growth phase with pricing advantage over originator, suggesting expanding sales force and commercial infrastructure development.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar
Started Mar 2025
225 enrolled
Crohn DiseasePlaque Psoriasis
Career Relevance
STEQEYMA is a newly launched biosimilar with zero linked jobs currently indexed, indicating early commercial build-out phase. Careers on this product focus on rapid market penetration, payer education, and competitive displacement of reference product share.
Brand Manager
Worked on STEQEYMA at Celltrion? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.